Latest news on Laboratorytalk categorised by supplier
Microbix Biosystems
Address:
341 Bering Ave
Toronto
Canada
Telephone: (Canada) +1 416 234 1624
http://www.microbix.com
Our RSS feed for news from Microbix Biosystems
Request to receive our free email newsletter each week
Listing of all 12 news releases from Microbix Biosystems:
Microbix announces changes to board of directors
Vaughn Embro-Pantalony has been appointed to the board of directors, replacing James A Long who has assumed his duties as chief financial officer, and has resigned as a director
News from Microbix Biosystems (15 February 2007)
Semen-sexing system has market potential
Technology can separate male-producing sperm from female-producing sperm, thus ensuring the desired sex of offspring for use in commercial cattle and swine livestock production
News from Microbix Biosystems ( 5 October 2005)
Flu technology attracts interest
Microbix enters exclusive review and negotiation period for proprietary influenza virus yield enhancement technology
News from Microbix Biosystems (23 June 2004)
Patent filed for new vaccine technology platform
New proprietary vaccine technology platform is said to have the potential to offer significant economic advantages to vaccine producers
News from Microbix Biosystems ( 2 July 2003)
Microbix raises financing to continue development
Microbix Biosystems has announced that it has completed a Canadian $500,000 Principal amount 8% convertible debenture, in a non-arms length transaction with an existing shareholder.
News from Microbix Biosystems (24 December 2002)
Mystery partner in urokinase deal
Generic version of Abbott's urokinase drug Abbokinase, for the treatment of pulmonary embolism or lung blood clots, to be developed in agreement with secretive partner
News from Microbix Biosystems (22 November 2002)
Agreement on adenovirus vector technology
Helper-dependent (HD) adenovirus vectors are being studied at the basic research level as potential tools for gene therapy and drug delivery
News from Microbix Biosystems (19 November 2002)
Successful third quarter
Microbix Biosystems reports profitable third quarter and 19% rise in sales
News from Microbix Biosystems (30 August 2002)
Biotech exec joins the board
Microbix biosystems announces the addition of a biotechnology executive Patrick Walsh to its board of directors
News from Microbix Biosystems ( 2 August 2002)
New York panel on generic biologics
Generic Pharmaceutical Association's workshop on regulatory and legislative issues hears industry views on characterisation of active pharmaceutical ingredients
News from Microbix Biosystems (22 March 2002)
Microbix on generic biologics panel
Microbix Biosystems will participate in a four-member FDA-sponsored panel to address issues of comparability and equivalence at the 6th WCBP Symposium in Washington
News from Microbix Biosystems ( 5 February 2002)
TransAtlantic cell evolution
Nautilus Biotech of France and Microbix Biosystems of Canada announce a distribution agreement for academic applications of NautCell, a high-producer cell-line for recombinant Adeno-associated vectors
News from Microbix Biosystems (30 January 2002)
